Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06848946 · ClinicalTrials.gov registry record · Phase 4

Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone

A Phase 4 study of Glaucoma Open-Angle and Phacoemulsification Cataract Surgery, sponsored by Glaukos Corporation.

Recruiting
Registry status
Phase 4
Development phase
132
Enrollment target
1
Study location

NCT06848946 is a Phase 4 study of Glaucoma Open-Angle and Phacoemulsification Cataract Surgery that is actively recruiting participants, run by Glaukos Corporation. The registered enrollment target is 132 participants, below the 159-participant average among 22 other Glaucoma Open-Angle trials with a reported enrollment target (17% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06848946, a Phase 4 study of Glaucoma Open-Angle and Phacoemulsification Cataract Surgery, is actively recruiting participants, sponsored by Glaukos Corporation.

RECRUITING
Registry status
Phase 4
Development phase
132 participants
Enrollment target
1
Study location

Study Summary

This trial will evaluate the safety and IOP -lowering efficacy of administering an iDose TR (travoprost intracameral implant) in conjunction with cataract surgery compared to cataract surgery alone

Conditions Studied

Glaucoma Open-Angle Phacoemulsification Cataract Surgery Ocular Hypertension (OHT)

Interventions

  • COMBINATION_PRODUCT iDose TR (travoprost intracameral implant) 75 µg in conjunction with cataract surgery
  • PROCEDURE Sham procedure in conjunction with cataract surgery

Study Locations (1)

Wisconsin

  • Glaukos Investigator Site - Kenosha

Trial Details

FieldValue
Enrollment Target 132 participants
Start Date 2025-01-13
Est. Completion 2027-06
Phase Phase 4

Sponsor

Glaukos Corporation

33 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06848946

The ClinicalTrials.gov registry entry for NCT06848946 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 159-participant average among 22 other Glaucoma Open-Angle trials with a reported enrollment target (17% lower). The listed sponsor is Glaukos Corporation, which has 33 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Glaucoma Open-Angle appearing as the primary indexed condition, and to 2 interventions - of which iDose TR (travoprost intracameral implant) 75 µg in conjunction with cataract surgery is the first listed.

NCT06848946 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06848946 about?

NCT06848946 is a clinical study titled "Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone". This trial will evaluate the safety and IOP -lowering efficacy of administering an iDose TR (travoprost intracameral implant) in conjunction with cataract surgery compared to cataract surgery alone

What is the current status of trial NCT06848946?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 132 participants. The study started on 2025-01-13. Estimated completion is 2027-06.

What conditions does trial NCT06848946 study?

This clinical trial studies the following conditions: Glaucoma Open-Angle, Phacoemulsification Cataract Surgery, Ocular Hypertension (OHT).

What interventions are being tested in trial NCT06848946?

The interventions under investigation include: iDose TR (travoprost intracameral implant) 75 µg in conjunction with cataract surgery (COMBINATION_PRODUCT), Sham procedure in conjunction with cataract surgery (PROCEDURE).

Who is sponsoring clinical trial NCT06848946?

This trial is sponsored by Glaukos Corporation, which has 33 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06848946 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Glaucoma Open-Angle

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Glaucoma Open-Angle

All registered trials for this condition

Phacoemulsification Cataract Surgery

All registered trials for this condition

Wisconsin

All trials with a study site in Wisconsin

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.